What is PulseOn?
PulseOn operates at the intersection of high-tech engineering and clinical cardiology, specializing in the development of sophisticated arrhythmia detection devices and proprietary analysis software. The company's core value proposition lies in its wearable technology, which utilizes high-fidelity optical heart-rate sensors to provide continuous, beat-to-beat monitoring. By focusing on the detection of atrial fibrillation—a condition frequently linked to stroke—PulseOn provides a non-intrusive, professional-grade solution that eliminates the need for complex patient training. This focus on seamless, long-term data collection allows for earlier clinical intervention and improved patient outcomes in a market increasingly demanding remote monitoring capabilities.
How much funding has PulseOn raised?
PulseOn has raised a total of $2.7M across 2 funding rounds:
Angel/Seed
$1.4M
Unspecified
$1.3M
Angel/Seed (2013): $1.4M, investors not publicly disclosed
Unspecified (2014): $1.3M, investors not publicly disclosed
Key Investors in PulseOn
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for PulseOn?
With this major enterprise-level funding, PulseOn is expected to scale its operational footprint and refine its diagnostic algorithms to meet the rigorous standards of global healthcare systems. The strategic roadmap likely involves expanding clinical validation studies and enhancing the interoperability of its software suite with existing electronic health record systems. As the company transitions from its initial development phase into a broader commercialization strategy, the focus will remain on solidifying its position as a leader in preventative cardiac care, ultimately aiming to reduce the global incidence of strokes through proactive, data-driven health management.
See full PulseOn company page
